Clinical Trials
22 trialsA Study of LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma
Lyvgen Biopharma Holdings Limited
Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.
Sun Yat-sen University
Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma
Nanfang Hospital, Southern Medical University
Sacituzumab Tirumotecan Plus Anlotinib for Metastatic Triple Negative Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
TALENT
The First Affiliated Hospital with Nanjing Medical University
Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
Sarcoma Oncology Research Center, LLC
AUTOMAN
Shanghai Chest Hospital
A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
AK104IIT018
Shanghai Chest Hospital
Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC
Shanghai Chest Hospital
Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer
Peking Union Medical College Hospital
Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC
Shanghai Chest Hospital
A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC
Sichuan Cancer Hospital and Research Institute
Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer
Sun Yat-sen University
A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
Shandong Cancer Hospital and Institute
AL3818
Advenchen Laboratories, LLC
Anlotinib and Irinotecan for Ewing Sarcoma
Peking University People's Hospital
Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma
ChineseAMS